The curious case of the White House official Trump says 'doesn't exist'

On Thursday the Trump administration held a "background briefing" where a "senior White House official" provided information to reporters from The New York Times, CNN and lots of other news outlets.

On Saturday, President Trump claimed the aide "doesn't exist."

It's a flagrant example of Trump's problem with the truth.

The president frequently claims, without evidence, that journalists make up sources. This is widely recognized to be a fib at best and a lie at worst.

He said it again in a tweet against The Times on Saturday: "Use real people, not phony sources."

But members of the White House press corps quickly pointed out that the unnamed "official" met with a roomful of reporters. Trump's claim was easily proven false.

To attend the briefing -- about the status of President Trump's possible summit with North Korean leader Kim Jong Un -- reporters had to agree to leave the aide's name out of their stories.

This tactic, a "background briefing," is frequently employed by White House press shops. Reporters regularly object to it, but it's a long standing fact of White House coverage.

At Thursday's briefing, the aide was asked to justify the anonymous nature of the Q&A, and the official said the White House wanted to "let the president's remarks stand."

So on Thursday the aide was identified in stories as "a senior White House official" or "a senior administration official."

The aide discussed Trump's surprise decision to cancel the June 12 summit between the United States and North Korea.

According to CNN's report, the official "downplayed the likelihood of the summit proceeding on course."

Among other things, the official said "the ball is in North Korea's court right now, and there's really not a lot of time."

The aide added, "June 12th is in 10 minutes."

By the next day, Trump was talking about rescheduling the summit. In a story for Saturday's paper, The New York Times pointed out the disconnect between what Trump was saying and what his aides had been saying.

The Times wrote: "On Thursday, for example, a senior White House official told reporters that even if the meeting were reinstated, holding it on June 12 would be impossible, given the lack of time and the amount of planning needed."

Trump singled out the "impossible" sentence in his faulty tweet on Saturday. He evidently objected to that word. Technically the aide did not say the June 12 date was "impossible," but that was the impression the Times reporters came away with, based on the tone and tenor of Thursday's briefing.

'If': The magic word for President Trump's conspiracy theory

Trump wrote on Saturday: "The Failing @nytimes quotes 'a senior White House official,' who doesn't exist, as saying "even if the meeting were reinstated, holding it on June 12 would be impossible, given the lack of time and the amount of planning needed." WRONG AGAIN! Use real people, not phony sources."

"Impossible" is open to interpretation. But the White House official definitely exists.

David Sanger, one of the two reporters who wrote the story, tweeted in response, "The reason that this official was not named in our story is that the White House press office insisted that its briefing -- for hundreds of reporters -- was on background. Best way to alleviate the President's concern about anonymous sources would be for WH to name the official."

Sanger's colleague Maggie Haberman added: "Imagine being the WH background briefer who led this briefing, who now has his boss -- the president of the US -- saying he/she doesn't exist."

The dust-up caused some onlookers to laugh and others to lament Trump's constant attacks against the press.

It also lent credence to "60 Minutes" correspondent Lesley Stahl's recent remarks about Trump's real anti-media agenda.

Stahl recalled saying to Trump, "That is getting tired, why are you doing it?"

According to Stahl, he replied, "You know why I do it? I do it to discredit you all and demean you all so when you write negative stories about me no one will believe you."

First Personal Financial Services Buys 6,508 Shares of Ishares Trust United States Treasury (TIP)

First Personal Financial Services boosted its stake in shares of Ishares Trust United States Treasury (NYSEARCA:TIP) by 29.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 28,538 shares of the exchange traded fund’s stock after purchasing an additional 6,508 shares during the period. First Personal Financial Services’ holdings in Ishares Trust United States Treasury were worth $3,226,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of TIP. WealthShield LLC bought a new stake in Ishares Trust United States Treasury in the fourth quarter valued at approximately $109,000. Farmers National Bank bought a new stake in Ishares Trust United States Treasury in the fourth quarter valued at approximately $114,000. C M Bidwell & Associates Ltd. bought a new stake in Ishares Trust United States Treasury in the fourth quarter valued at approximately $128,000. Trustcore Financial Services LLC bought a new stake in Ishares Trust United States Treasury in the fourth quarter valued at approximately $136,000. Finally, Harvest Fund Management Co. Ltd bought a new stake in Ishares Trust United States Treasury in the first quarter valued at approximately $136,000.

Get Ishares Trust United States Treasury alerts:

NYSEARCA:TIP opened at $111.96 on Friday. Ishares Trust United States Treasury has a 12-month low of $111.04 and a 12-month high of $115.26.

The firm also recently disclosed a monthly dividend, which was paid on Monday, May 7th. Shareholders of record on Wednesday, May 2nd were paid a $0.4991 dividend. This is a positive change from Ishares Trust United States Treasury’s previous monthly dividend of $0.29. The ex-dividend date of this dividend was Tuesday, May 1st. This represents a $5.99 annualized dividend and a yield of 5.35%.

About Ishares Trust United States Treasury

iShares TIPS Bond ETF (the Fund), formerly iShares Barclays Treasury Inflation Protected Securities Bond Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Barclays U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L) (the Index).

Comerica Bank Increases Position in Macerich Co (MAC)

Comerica Bank boosted its stake in Macerich Co (NYSE:MAC) by 3.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 34,144 shares of the real estate investment trust’s stock after acquiring an additional 1,244 shares during the period. Comerica Bank’s holdings in Macerich were worth $1,965,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Delpha Capital Management LLC purchased a new stake in Macerich in the fourth quarter valued at $156,000. Tower Research Capital LLC TRC lifted its position in Macerich by 870.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 3,260 shares of the real estate investment trust’s stock valued at $214,000 after acquiring an additional 2,924 shares during the last quarter. Harvest Management LLC purchased a new stake in Macerich in the first quarter valued at $224,000. Miracle Mile Advisors LLC purchased a new stake in Macerich in the fourth quarter valued at $250,000. Finally, Virtu Financial LLC purchased a new stake in Macerich in the fourth quarter valued at $254,000. 95.20% of the stock is owned by hedge funds and other institutional investors.

Get Macerich alerts:

NYSE MAC opened at $54.75 on Friday. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 1.56. The firm has a market capitalization of $7.76 billion, a price-to-earnings ratio of 13.93, a price-to-earnings-growth ratio of 2.07 and a beta of 0.85. Macerich Co has a one year low of $52.12 and a one year high of $69.73.

Macerich (NYSE:MAC) last posted its quarterly earnings data on Wednesday, May 2nd. The real estate investment trust reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($1.05). The business had revenue of $212.38 million during the quarter, compared to analyst estimates of $216.47 million. Macerich had a net margin of 4.40% and a return on equity of 1.48%. The company’s revenue for the quarter was down 3.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.87 earnings per share. equities analysts anticipate that Macerich Co will post 3.96 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 1st. Shareholders of record on Tuesday, May 8th will be paid a $0.74 dividend. The ex-dividend date is Monday, May 7th. This represents a $2.96 dividend on an annualized basis and a yield of 5.41%. Macerich’s dividend payout ratio is presently 75.32%.

A number of equities research analysts recently weighed in on the stock. Barclays reduced their price target on shares of Macerich from $62.00 to $60.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 30th. Mizuho set a $63.00 price target on shares of Macerich and gave the company a “hold” rating in a research report on Friday, February 16th. BMO Capital Markets set a $62.00 price target on shares of Macerich and gave the company a “hold” rating in a research report on Monday, February 5th. Boenning Scattergood reissued a “buy” rating and issued a $75.00 price target on shares of Macerich in a research report on Wednesday, February 7th. Finally, Morgan Stanley reissued a “hold” rating on shares of Macerich in a research report on Tuesday, February 6th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and six have issued a buy rating to the stock. Macerich presently has an average rating of “Hold” and an average target price of $65.10.

Macerich Company Profile

Macerich, an S&P 500 company, is a fully integrated self-managed and self-administered real estate investment trust, which focuses on the acquisition, leasing, management, development and redevelopment of regional malls throughout the United States. Macerich currently owns 53 million square feet of real estate consisting primarily of interests in 48 regional shopping centers.

Want to see what other hedge funds are holding MAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Macerich Co (NYSE:MAC).

$176.40 Million in Sales Expected for NNN Healthcare/Office REIT Inc (HTA) This Quarter

Equities analysts expect that NNN Healthcare/Office REIT Inc (NYSE:HTA) will announce sales of $176.40 million for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for NNN Healthcare/Office REIT’s earnings, with the lowest sales estimate coming in at $174.30 million and the highest estimate coming in at $177.90 million. NNN Healthcare/Office REIT posted sales of $139.88 million during the same quarter last year, which would indicate a positive year over year growth rate of 26.1%. The business is scheduled to issue its next earnings report on Monday, July 30th.

According to Zacks, analysts expect that NNN Healthcare/Office REIT will report full-year sales of $709.35 million for the current fiscal year, with estimates ranging from $700.97 million to $718.30 million. For the next financial year, analysts forecast that the firm will post sales of $737.28 million per share, with estimates ranging from $716.28 million to $758.30 million. Zacks Investment Research’s sales averages are an average based on a survey of analysts that follow NNN Healthcare/Office REIT.

Get NNN Healthcare/Office REIT alerts:

NNN Healthcare/Office REIT (NYSE:HTA) last issued its earnings results on Monday, April 30th. The real estate investment trust reported $0.05 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.37). NNN Healthcare/Office REIT had a return on equity of 1.82% and a net margin of 9.04%. The firm had revenue of $175.60 million for the quarter, compared to analysts’ expectations of $175.17 million. During the same quarter in the previous year, the firm posted $0.41 EPS. The firm’s revenue for the quarter was up 41.3% compared to the same quarter last year.

A number of analysts have recently issued reports on HTA shares. Zacks Investment Research upgraded NNN Healthcare/Office REIT from a “sell” rating to a “hold” rating in a report on Wednesday, April 25th. Jefferies Group reiterated a “buy” rating and set a $32.00 target price on shares of NNN Healthcare/Office REIT in a report on Monday, March 26th. Morgan Stanley decreased their target price on NNN Healthcare/Office REIT from $33.00 to $30.00 and set an “overweight” rating for the company in a report on Tuesday, March 20th. Stifel Nicolaus decreased their target price on NNN Healthcare/Office REIT from $35.00 to $32.00 and set a “hold” rating for the company in a report on Friday, February 16th. Finally, BMO Capital Markets set a $31.00 target price on NNN Healthcare/Office REIT and gave the stock a “buy” rating in a report on Monday, March 26th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $31.82.

In other NNN Healthcare/Office REIT news, CEO Scott D. Peters sold 77,425 shares of the company’s stock in a transaction that occurred on Monday, April 9th. The stock was sold at an average price of $26.28, for a total value of $2,034,729.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.90% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Kempen Capital Management N.V. boosted its holdings in NNN Healthcare/Office REIT by 66.0% in the 1st quarter. Kempen Capital Management N.V. now owns 452,165 shares of the real estate investment trust’s stock worth $11,960,000 after acquiring an additional 179,795 shares during the period. Principal Financial Group Inc. boosted its holdings in NNN Healthcare/Office REIT by 6.2% in the 1st quarter. Principal Financial Group Inc. now owns 4,107,229 shares of the real estate investment trust’s stock worth $108,636,000 after acquiring an additional 241,551 shares during the period. Xact Kapitalforvaltning AB boosted its holdings in NNN Healthcare/Office REIT by 67.0% in the 1st quarter. Xact Kapitalforvaltning AB now owns 22,683 shares of the real estate investment trust’s stock worth $600,000 after acquiring an additional 9,100 shares during the period. Royal Bank of Canada boosted its holdings in NNN Healthcare/Office REIT by 5.4% in the 1st quarter. Royal Bank of Canada now owns 4,938,837 shares of the real estate investment trust’s stock worth $130,631,000 after acquiring an additional 251,499 shares during the period. Finally, McKinley Carter Wealth Services Inc. purchased a new position in NNN Healthcare/Office REIT in the 1st quarter worth approximately $120,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Shares of NYSE:HTA traded up $0.33 during trading on Wednesday, reaching $24.78. 1,453,780 shares of the stock were exchanged, compared to its average volume of 1,467,850. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.51 and a current ratio of 1.51. NNN Healthcare/Office REIT has a 12-month low of $24.06 and a 12-month high of $32.83. The stock has a market capitalization of $5.05 billion, a P/E ratio of 15.20, a PEG ratio of 3.66 and a beta of 0.20.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 10th. Shareholders of record on Thursday, July 5th will be issued a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a yield of 4.92%. The ex-dividend date is Tuesday, July 3rd. NNN Healthcare/Office REIT’s dividend payout ratio is presently 74.85%.

NNN Healthcare/Office REIT Company Profile

Healthcare Trust of America, Inc (NYSE: HTA) is the largest dedicated owner and operator of medical office buildings ("MOBs") in the United States based on gross leasable area ("GLA"). We provide the real estate infrastructure for the integrated delivery of healthcare services in highly desirable locations.

Get a free copy of the Zacks research report on NNN Healthcare/Office REIT (HTA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Robeco Institutional Asset Management B.V. Buys 47,140 Shares of Anadarko Petroleum Co. (APC)

Robeco Institutional Asset Management B.V. increased its stake in shares of Anadarko Petroleum Co. (NYSE:APC) by 258.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 65,409 shares of the oil and gas development company’s stock after purchasing an additional 47,140 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Anadarko Petroleum were worth $3,952,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of APC. Schwab Charles Investment Management Inc. lifted its holdings in shares of Anadarko Petroleum by 1.0% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 2,173,067 shares of the oil and gas development company’s stock worth $116,564,000 after purchasing an additional 21,214 shares during the period. State of Alaska Department of Revenue lifted its holdings in shares of Anadarko Petroleum by 297.2% during the fourth quarter. State of Alaska Department of Revenue now owns 58,392 shares of the oil and gas development company’s stock worth $3,130,000 after purchasing an additional 43,692 shares during the period. Steward Partners Investment Advisory LLC lifted its holdings in shares of Anadarko Petroleum by 186.6% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 6,810 shares of the oil and gas development company’s stock worth $365,000 after purchasing an additional 4,434 shares during the period. Chevy Chase Trust Holdings Inc. lifted its holdings in shares of Anadarko Petroleum by 6.2% during the fourth quarter. Chevy Chase Trust Holdings Inc. now owns 682,161 shares of the oil and gas development company’s stock worth $36,591,000 after purchasing an additional 39,942 shares during the period. Finally, First Manhattan Co. lifted its holdings in shares of Anadarko Petroleum by 5.0% during the fourth quarter. First Manhattan Co. now owns 22,940 shares of the oil and gas development company’s stock worth $1,230,000 after purchasing an additional 1,093 shares during the period. 89.21% of the stock is owned by hedge funds and other institutional investors.

Get Anadarko Petroleum alerts:

Several equities research analysts recently weighed in on APC shares. Credit Suisse Group set a $71.00 price target on Anadarko Petroleum and gave the stock a “buy” rating in a report on Tuesday, January 23rd. They noted that the move was a valuation call. Stifel Nicolaus reiterated a “buy” rating and issued a $76.00 price objective (up previously from $73.00) on shares of Anadarko Petroleum in a research report on Wednesday, February 7th. Zacks Investment Research upgraded Anadarko Petroleum from a “hold” rating to a “buy” rating and set a $65.00 price objective for the company in a research report on Wednesday, February 14th. Piper Jaffray Companies set a $72.00 price objective on Anadarko Petroleum and gave the stock a “buy” rating in a research report on Sunday, February 11th. Finally, Jefferies Group reiterated a “buy” rating and issued a $78.00 price objective on shares of Anadarko Petroleum in a research report on Thursday, February 8th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have assigned a buy rating to the stock. Anadarko Petroleum currently has an average rating of “Buy” and an average target price of $67.60.

Shares of Anadarko Petroleum opened at $71.71 on Tuesday, MarketBeat.com reports. Anadarko Petroleum Co. has a fifty-two week low of $39.96 and a fifty-two week high of $72.15. The firm has a market capitalization of $36.35 billion, a PE ratio of -36.59, a PEG ratio of 2.78 and a beta of 1.26. The company has a debt-to-equity ratio of 1.33, a current ratio of 1.17 and a quick ratio of 1.17.

Anadarko Petroleum (NYSE:APC) last announced its quarterly earnings results on Tuesday, May 1st. The oil and gas development company reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.09. Anadarko Petroleum had a negative return on equity of 3.44% and a negative net margin of 0.15%. The business had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $3.14 billion. During the same quarter last year, the business posted ($0.60) earnings per share. The business’s revenue for the quarter was down 19.2% on a year-over-year basis. sell-side analysts anticipate that Anadarko Petroleum Co. will post 2.54 earnings per share for the current fiscal year.

Anadarko Petroleum declared that its Board of Directors has authorized a share repurchase plan on Wednesday, February 7th that permits the company to repurchase $500.00 million in shares. This repurchase authorization permits the oil and gas development company to reacquire shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 27th. Stockholders of record on Wednesday, June 13th will be given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date is Tuesday, June 12th. Anadarko Petroleum’s dividend payout ratio is currently -51.02%.

About Anadarko Petroleum

Anadarko Petroleum Corporation engages in the exploration, development, production, and marketing of oil and gas properties. It operates through three segments: Exploration and Production, WES Midstream, and Other Midstream. The company explores for and produces oil, natural gas, and natural gas liquids (NGLs).

Want to see what other hedge funds are holding APC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anadarko Petroleum Co. (NYSE:APC).

Woolworths Dismisses Australia CEO After $541 Million Writedown

Woolworths Holdings Ltd. said Australian division head John Dixon will leave and won’t be replaced after South Africa’s biggest clothing and food retailer was forced to write off 712.5 million Australian dollars ($541 million) from the country’s David Jones business earlier this year.

The heads of David Jones and clothes retailer Country Road now will both report directly to Woolworths Chief Executive Officer Ian Moir, the Cape Town-based company said in a statement Tuesday, citing a review of costs.

Woolworths bought the David Jones department-store chain for about $2 billion in 2014. It announced the writedown in January, saying a downturn in the Australian retailer sector and poor or delayed execution of some company initiatives had reduced the value.

The shares were little changed at 59.88 rand as of 11:27 a.m. in Johannesburg, valuing the company at 63 billion rand ($5 billion).

Share Share on Facebook Post to Twitter Send as an Email Print

Massachusetts Financial Services Co. MA Reduces Stake in Molina Healthcare (MOH)

Massachusetts Financial Services Co. MA lessened its position in Molina Healthcare (NYSE:MOH) by 56.6% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 190,063 shares of the company’s stock after selling 247,884 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Molina Healthcare were worth $15,429,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of MOH. Amundi Pioneer Asset Management Inc. bought a new stake in shares of Molina Healthcare in the 4th quarter worth $100,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Molina Healthcare by 40.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,404 shares of the company’s stock worth $184,000 after buying an additional 690 shares in the last quarter. Connable Office Inc. bought a new stake in shares of Molina Healthcare in the 4th quarter worth $203,000. Xact Kapitalforvaltning AB bought a new stake in shares of Molina Healthcare in the 4th quarter worth $310,000. Finally, PEAK6 Investments L.P. raised its stake in shares of Molina Healthcare by 187.1% in the 4th quarter. PEAK6 Investments L.P. now owns 4,140 shares of the company’s stock worth $317,000 after buying an additional 2,698 shares in the last quarter.

Get Molina Healthcare alerts:

In other news, Director John C. Molina sold 62,420 shares of Molina Healthcare stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $72.13, for a total transaction of $4,502,354.60. Following the transaction, the director now owns 393,410 shares in the company, valued at $28,376,663.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John C. Molina sold 20,741 shares of Molina Healthcare stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $72.36, for a total value of $1,500,818.76. Following the transaction, the director now owns 393,410 shares in the company, valued at approximately $28,467,147.60. The disclosure for this sale can be found here. Insiders have sold 87,061 shares of company stock worth $6,305,956 in the last quarter. 0.65% of the stock is currently owned by corporate insiders.

Shares of NYSE MOH opened at $87.60 on Friday. The company has a debt-to-equity ratio of 0.98, a quick ratio of 1.36 and a current ratio of 1.36. The firm has a market capitalization of $5.40 billion, a P/E ratio of 27.63, a P/E/G ratio of 1.39 and a beta of 1.20. Molina Healthcare has a 52-week low of $56.67 and a 52-week high of $93.98.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Monday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.81 by $0.90. The business had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.74 billion. Molina Healthcare had a positive return on equity of 20.08% and a negative net margin of 2.46%. The company’s quarterly revenue was down 5.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.63 EPS. research analysts expect that Molina Healthcare will post 4.63 EPS for the current fiscal year.

A number of analysts have recently commented on the company. Morgan Stanley boosted their price objective on Molina Healthcare from $91.00 to $100.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 1st. ValuEngine raised Molina Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, March 2nd. BMO Capital Markets dropped their price objective on Molina Healthcare from $98.00 to $85.00 and set a “market perform” rating on the stock in a research note on Wednesday, February 14th. Jefferies Group reissued a “hold” rating and issued a $80.00 price objective on shares of Molina Healthcare in a research note on Wednesday, February 14th. Finally, Zacks Investment Research raised Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $96.00 price objective on the stock in a research note on Tuesday, April 17th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. Molina Healthcare currently has a consensus rating of “Hold” and a consensus target price of $80.92.

Molina Healthcare Profile

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare (NYSE:MOH).